Skip to main navigation Skip to search Skip to main content

A Randomized Comparison of Nivolumab versus Nivolumab+Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630

  • Yuri Taniguchi
  • , Tsuneo Shimokawa
  • , Yuichi Takiguchi
  • , Toshihiro Misumi
  • , Yukiko Nakamura
  • , Yosuke Kawashima
  • , Naoki Furuya
  • , Yoshimasa Shiraishi
  • , Toshiyuki Harada
  • , Hisashi Tanaka
  • , Satoru Miura
  • , Ayumi Uchiyama
  • , Yoshiro Nakahara
  • , Takaaki Tokito
  • , Katsuhiko Naoki
  • , Akihiro Bessho
  • , Yasuhiro Goto
  • , Masahiro Seike
  • , Hiroaki Okamoto

Research output: Contribution to journal › Article › peer-review

23   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'A Randomized Comparison of Nivolumab versus Nivolumab+Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases